| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 35.19B | 32.20B | 31.38B | 30.07B | 72.95B |
| Gross Profit | 21.90B | 19.25B | 20.70B | 19.98B | 62.44B |
| EBITDA | 2.67B | -5.69B | 10.30B | -5.31B | 31.50B |
| Net Income | 1.28B | -7.19B | 5.81B | -9.32B | 30.33B |
Balance Sheet | |||||
| Total Assets | 218.70B | 226.34B | 231.43B | 216.28B | 231.61B |
| Cash, Cash Equivalents and Short-Term Investments | 93.97B | 111.29B | 119.14B | 121.01B | 121.36B |
| Total Debt | 62.05B | 65.88B | 73.02B | 59.98B | 58.77B |
| Total Liabilities | 141.01B | 148.65B | 139.29B | 134.30B | 134.39B |
| Stockholders Equity | 75.58B | 75.42B | 89.25B | 80.03B | 95.74B |
Cash Flow | |||||
| Free Cash Flow | -6.71B | 16.79B | -13.95B | 11.29B | 4.20B |
| Operating Cash Flow | -6.36B | 17.39B | -11.03B | 13.47B | 7.06B |
| Investing Cash Flow | -7.08B | -10.04B | -8.76B | 1.63B | -7.98B |
| Financing Cash Flow | -3.80B | -14.92B | 15.93B | -5.21B | 6.24B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
85 Outperform | ¥28.14B | 11.97 | ― | 0.73% | 17.32% | 33.18% | |
70 Outperform | ¥24.64B | 50.86 | ― | ― | 31.09% | 75.74% | |
68 Neutral | ¥138.84B | 13.67 | 11.52% | 2.76% | 4.79% | 15.28% | |
65 Neutral | ¥30.17B | 20.84 | 10.34% | 4.82% | -2.76% | 36.33% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
49 Neutral | ¥100.23B | 69.81 | 2.57% | 1.97% | 9.27% | ― |